Popular genetics company 23andMe is partnering up with drug giant GlaxoSmithKline to use people's DNA to develop medical treatments, the company announced in a blog post yesterday (July 25).
23andMe Is Sharing Its 5 Million Clients' Genetic Data with Drug Giant GlaxoSmithKline
Live Science - 26 Jul 2018 18:39
Popular genetics company 23andMe is partnering up with drug giant GlaxoSmithKline to use people's DNA to develop medical treatments, the company announced in a blog post yesterday (July 25).
Share this Article
Comment on this Article
Recommended
Please to comment